Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

CRF antagonists added to DuPont patent portfolio

Aug. 30, 2001

Four centers added to Neotrofin Parkinson's disease trial

Aug. 30, 2001

Orion and Pharmacia agree to develop antianxiety treatment for the U.S. market

Aug. 30, 2001

AMPA receptor antagonists presented by Kyorin

Aug. 29, 2001

GSK claims new adenosine A1 agonist formulations for the treatment of pain

Aug. 29, 2001

Neuron-selective Ca channel blocker discovered at Eisai

Aug. 29, 2001

Dexmethylphenidate hydrochloride receives FDA approvable letter for ADHD

Aug. 29, 2001

Efexor XR, a long-term alternative to benzodiazepines in treating anxiety

Aug. 29, 2001

NeuroSearch patents nACh receptor modulators

Aug. 28, 2001

BMS patents compounds having unique dopaminergic and serotonergic activity

Aug. 28, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 6, 2026.
CINP 2026: Prenatal and adolescent stress shape brain vulnerability
BioWorld Science
Human biology is extraordinarily complex, and that sophistication emerges from the very beginning. During embryonic and fetal development, the organism’s...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neuracle eyes Shanghai IPO as global BCI funding surges
BioWorld
Neuracle Medical Technology Co. Ltd. is seeking a Shanghai IPO that could make it China’s first publicly listed invasive brain-computer interface (BCI) company,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...